Chicago Partners Investment Group LLC grew its stake in Danaher Co. (NYSE:DHR) by 17.9% in the 3rd quarter, Holdings Channel reports. The firm owned 4,607 shares of the conglomerate’s stock after purchasing an additional 700 shares during the period. Chicago Partners Investment Group LLC’s holdings in Danaher were worth $446,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. IMS Capital Management bought a new stake in shares of Danaher in the 2nd quarter valued at approximately $107,000. BerganKDV Wealth Management LLC bought a new stake in shares of Danaher in the 2nd quarter valued at approximately $111,000. Fort L.P. bought a new stake in shares of Danaher in the 2nd quarter valued at approximately $119,000. Braun Bostich & Associates Inc. lifted its stake in shares of Danaher by 506.4% in the 2nd quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after purchasing an additional 1,023 shares during the last quarter. Finally, Reilly Financial Advisors LLC lifted its stake in shares of Danaher by 62.6% in the 3rd quarter. Reilly Financial Advisors LLC now owns 1,301 shares of the conglomerate’s stock valued at $141,000 after purchasing an additional 501 shares during the last quarter. 76.80% of the stock is owned by institutional investors and hedge funds.
Several research firms have recently issued reports on DHR. Zacks Investment Research lowered Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, July 24th. Bank of America set a $113.00 price objective on Danaher and gave the company a “buy” rating in a research note on Thursday, July 19th. Robert W. Baird lowered their price objective on Danaher from $116.00 to $114.00 and set an “outperform” rating for the company in a research note on Friday, October 19th. Royal Bank of Canada raised their price objective on Danaher to $107.00 and gave the company a “positive” rating in a research note on Thursday, July 19th. They noted that the move was a valuation call. Finally, Morgan Stanley increased their price target on Danaher from $113.00 to $120.00 and gave the stock an “overweight” rating in a report on Friday, July 13th. One equities research analyst has rated the stock with a hold rating and fifteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $112.14.
In other Danaher news, CFO Daniel L. Comas sold 36,000 shares of the firm’s stock in a transaction on Thursday, November 8th. The stock was sold at an average price of $103.88, for a total transaction of $3,739,680.00. Following the transaction, the chief financial officer now directly owns 124,218 shares in the company, valued at approximately $12,903,765.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 5,212 shares of the firm’s stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $103.89, for a total value of $541,474.68. Following the transaction, the insider now owns 151,829 shares in the company, valued at $15,773,514.81. The disclosure for this sale can be found here. Over the last quarter, insiders sold 150,007 shares of company stock worth $15,202,163. Company insiders own 11.90% of the company’s stock.
Shares of NYSE DHR opened at $104.39 on Friday. The company has a current ratio of 1.53, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38. Danaher Co. has a fifty-two week low of $91.65 and a fifty-two week high of $110.13. The company has a market capitalization of $72.94 billion, a PE ratio of 25.90, a price-to-earnings-growth ratio of 2.00 and a beta of 1.04.
Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, October 18th. The conglomerate reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.03. Danaher had a return on equity of 11.59% and a net margin of 14.07%. The firm had revenue of $4.85 billion for the quarter, compared to the consensus estimate of $4.80 billion. During the same period in the prior year, the business posted $1.00 earnings per share. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. On average, equities research analysts anticipate that Danaher Co. will post 4.51 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, October 26th. Stockholders of record on Friday, September 28th were issued a $0.16 dividend. The ex-dividend date of this dividend was Thursday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 0.61%. Danaher’s payout ratio is 15.88%.
WARNING: This story was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/11/10/chicago-partners-investment-group-llc-has-446000-stake-in-danaher-co-dhr.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
See Also: What strategies should day traders use to execute a trade?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.